News

The API facilities are expected to be completed by 2012-13, reports business-standard. Through its partners in China, the company is also involved in developing bio- similars/ bio-therapeutic products

Mylan’s Nashik, India facility produces the company’s finished-dosage-form ARVs for markets around the world including India. Mylan CEO Heather Bresch said the company can set a new standard

The acquisition will enable Accenture to help its pharmaceutical clients by providing comprehensive services spanning regulatory operations, submissions management, clinical data conversion and clinical data management. Accenture said

The company is a PRC-based manufacturer and marketer of pharmaceutical and health supplement products in China for a variety of diseases and conditions. Biostar chief executive officer and

Zaltrap is an angiogenesis inhibitor which inhibits the blood supply to tumors. FDA has approved Zaltrap following a Priority Review and a data collected from the pivotal Phase

The JV will develop a family of Apo E mimetic peptides licensed from The UAB Research Foundation (UABRF). Under the JV agreement, Capstone will contribute $6m, while LipimetiX

In a mouse model of PKD, treatment with a folate-conjugated form of rapamycin, FC-rapa, (EC0371) attenuated proliferation and growth of renal cysts and preserved renal function. Endocyte has

HP802-247 is an investigational allogeneic living cell bioformulation that contains keratinocytes and fibroblasts currently under development for venous leg ulcers treatment. Healthpoint Biotherapeutics chief medical officer Bert Slade

iPS Academia Japan, an affiliate of Kyoto University, is engaged in managing and utilizing the patents and other intellectual properties in the field of iPSC technologies so that